WhichPeps

BPC-157 + TB-500 blend

Multi-peptide blend

Also known as: Wolverine· community blend nameWolverine Stack· community blend name
Tissue-repair and recov…
Generic peptide vial illustrationBPC-157 + TB-500 blend
Evidence levelHuman evidence
Human evidenceNone established
Regulatory statusNo approved medicine identified

What you need to know in 20 seconds

What is it?Multi-peptide blend
Research focusTissue-repair and recovery claims
Human evidenceNo controlled human clinical trial of the BPC-157 + TB-500 combination was identified.
Regulatory statusNo approved medicine corresponding to this blend was identified.
Main limitationsHuman synergy, efficacy, safety, optimal ratio or dosing of the blend.
SafetyUnknown interaction, purity and immunogenicity risks in addition to component-specific uncertainty.
i
No controlled human clinical trial of the BPC-157 + TB-500 combination was identified.

What the evidence actually supports

  • ✓Replace broad 'no combination evidence' wording with 'preclinical combination evidence exists; human combination evidence does not.'

What is not established / key limitations

  • ×No additive benefit was demonstrated versus monotherapy in this exploratory model.

Selected study & evidence records

BPC-157 + TB-500 combination arm in rat Achilles tendon repair

2026 · Randomized animal experiment · n=32

The combination improved some histologic measures versus control but did not provide additional benefit over either agent alone.

Study detail → Primary source ↗

Safety and unknowns

Unknown interaction, purity and immunogenicity risks in addition to component-specific uncertainty.

Unknown interaction, purity and immunogenicity risks in addition to component-specific uncertainty.

Technical details

Mechanism / biologyCombines two investigational peptides; no validated combined mechanism or interaction profile has been established clinically.
Route / formulation boundaryTotal milligrams do not define the ratio or identity unless the product label/COA provides it.
Identity / data-quality noteUse the canonical compound identity and studied formulation when interpreting evidence.
Dosing evidence statusDosing research conclusion recorded. No clinical regimen for the BPC-157 + TB-500 blend identified; component studies do not establish a blend dose.
Identifiers & alternate namesWolverine · Wolverine Stack · BPC/TB blend

Evidence rule: WhichPeps keeps human, animal, laboratory, regulatory and product/formulation evidence distinct. Common names help people find the page; they do not change the underlying scientific identity.